Eberhard Schulz

Showing 1-3 of 3 articles

Coronary interventions

Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Münzel T, Cequier A, Buono A, Serruys P, Sabaté M

March 20, 2020 | 10.4244/EIJ-D-19-00773

Interventions for valvular disease

Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants

von Bardeleben R, Hobohm L, Kreidel F, Ostad MA, Schulz E, Konstantinides S, Lankeit M, Feldman T, Münzel T, Keller K

April 16, 2019 | 10.4244/EIJ-D-18-00961

Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes

Gori T, Schulz E, Hink U, Wenzel P, Post F, Jabs A, Münzel T

January 20, 2014 | 10.4244/EIJV9I9A176

1

Latest news

State-of-the-Art on Glucose Management, Diabetes and PCI; a Mini Focus on CTOs and more...

October 1, 2021

The FAST II study

Kaneshka Masdjedi et al.

October 14, 2021

OCT-guided PCI in iatrogenic artery stenosis

Zvonimir Ostojic et al.

October 14, 2021

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

October 15, 2021

Transfemoral transcatheter tricuspid valve replacement after failed leaflet repair

Mirjam G. Wild et al.

October 14, 2021

STATE OF THE ART

Glucose-Lowering Therapy in Patients undergoing Percutaneous Coronary Intervention

Isabelle Johansson et al.

October 1, 2021

Predictors of rotational atherectomy

Sean Fitzgerald et al.

October 6, 2021

Valvular disease